Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, plays a significant role in regulating appetite and food intake
Current research investigating potential advantages beyond glycaemic regulation and weight reduction, including impacts on non-alcoholic fatty liver disease, cardiovascular outcomes, and renal protection, may broaden the therapeutic uses of these medicines
Transmission electron microscopy (HT7800 HITACHI) was used for examination
If you take GLP-1 drugs to manage your weight or improve your health, you should be aware of the possible risks
Cognition in healthy, older adults may also be improved with supplementation that improves glutathione levels (10)
As a result, clinicians can respond quickly and adjust treatment as needed